Effects of yolkin on the immune response of mice and its plausible mechanism of action.
Animals
B-Lymphocytes
/ drug effects
CD8-Positive T-Lymphocytes
/ drug effects
Female
Humans
Immunity, Cellular
/ drug effects
Immunity, Humoral
/ drug effects
Jurkat Cells
Lymph Nodes
/ drug effects
Lymphocyte Activation
/ drug effects
Male
Mice
Mice, Inbred BALB C
Sheep
Spleen
/ immunology
Thymocytes
/ drug effects
Thymus Gland
/ immunology
Vitellogenins
/ immunology
Contact sensitivity
Egg proteins
Humoral immune response
MAP kinases
T and B cells
Yolkin
Journal
Immunology letters
ISSN: 1879-0542
Titre abrégé: Immunol Lett
Pays: Netherlands
ID NLM: 7910006
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
17
04
2019
revised:
02
09
2019
accepted:
13
01
2020
pubmed:
20
1
2020
medline:
18
12
2020
entrez:
20
1
2020
Statut:
ppublish
Résumé
Yolkin is a product of proteolytic degradation of vitellogenin, a protein contained in eggs' yolk, with already described procognitive properties. Here, we investigated effects of yolkin on the humoral and cellular immune response in mice, phenotype of cells from lymphoid organs and function of innate immunity cells. In vitro studies included effects of yolkin on mitogen-induced thymocyte proliferation, percentage of CD19 cells in bone marrow cells culture, expression of signaling molecules in Jurkat cells, interleukin 2 receptor (IL-2R) subunits in WEHI 231 cells and susceptibility of these cells to anti-Ig-induced cell death. The results showed that repeatable i.p. injections of yolkin stimulated the humoral immune response to sheep red blood cells (SRBC) irrespective of the time of the treatment. On the other hand, yolkin inhibited contact sensitivity to oxazolone. Treatment of mice with yolkin diminished the percentage of double positive cells and increasing the content of single positive CD4+ and CD8+ cells in the thymus. At the same time an increase of percentage of CD19 + B cells in the spleen and mesenteric lymph nodes was observed. In addition, the protein, given i.p., diminished ex vivo ability to synthesize nitric oxide by resident, peritoneal macrophages, stimulated with lipopolisaccharide (LPS). In vitro studies showed that yolkin increased CD19+ cell content in bone marrow cell population. The protein also enhanced proliferation of thymocytes to concanavalin A and stimulated expression of MAP kinases in Jurkat cells. In WEHI 231 B cell line yolkin caused a loss of IL-2R gamma chain expression, correlated with an increased resistance of these cells to proapoptotic action of anti-Ig antibodies. In conclusion, this is a first demonstration of immunotropic properties of yolkin in in vitro and in vivo tests. The results provide evidence for induction of maturation and stimulatory signals in immature T and B cells by the protein, suggesting its potential role in the development of an embryo's immune system.
Identifiants
pubmed: 31954800
pii: S0165-2478(19)30207-X
doi: 10.1016/j.imlet.2020.01.003
pii:
doi:
Substances chimiques
Vitellogenins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21-31Informations de copyright
Copyright © 2020 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.